SAN DIEGO (AP) _ Ligand Pharmaceuticals Inc. (LGND) on Monday reported first-quarter net income of $18.1 million, after reporting a loss in the same period a year earlier.
On a per-share basis, the San Diego-based company said it had profit of $1.05. Earnings, adjusted for one-time gains and costs, came to $1.41 per share.
The drugmaker posted revenue of $55.2 million in the period.
Ligand expects full-year earnings to be $6.15 per share, with revenue expected to be $291 million.
Ligand shares have increased 45% since the beginning of the year. In the final minutes of trading on Monday, shares hit $144.28, a climb of 55% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LGND at https://www.zacks.com/ap/LGND
∎